Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis Lesions.

Samantha A Banks Waleed Brinjikji Caterina Giannini Stephanie B Syc-Mazurek Helena K Xeros Michel Toledano Rafid Mustafa Ivan D Carabenciov W Oliver Tobin

Neurology

From the Departments of Neurology (S.A.B., S.B.S-M., H.K.X., M.T., R.M., I.D.C., W.O.T.), Radiology (W.B.), Anatomic Pathology (C.G.), and Center for MS and Autoimmune Neurology (W.O.T.), Mayo Clinic, Rochester, MN.

Published: September 2024

Download full-text PDF	Source
http://dx.doi.org/10.1212/WNL.0000000000209739	DOI Listing

Publication Analysis

Top Keywords

intra-arterial melphalan

melphalan targeted

targeted therapy

therapy tumefactive

tumefactive multiple

multiple sclerosis

sclerosis lesions

intra-arterial

targeted

therapy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!